137 related articles for article (PubMed ID: 34537776)
1. COVID-19 Infection in Sickle Cell Patients in a Developing Country: A Case Series.
Silva-Pinto AC; Santos-Oliveira L; Santos FLS; Kashima Haddad S; De Santis GC; do Tocantins Calado R
Acta Haematol; 2022; 145(1):1-4. PubMed ID: 34537776
[TBL] [Abstract][Full Text] [Related]
2. Severe COVID-19 with acute respiratory distress syndrome (ARDS) in a sickle cell disease adult patient: case report.
Teulier M; Elabbadi A; Gerotziafas G; Lionnet F; Voiriot G; Fartoukh M
BMC Pulm Med; 2021 Jan; 21(1):46. PubMed ID: 33514354
[TBL] [Abstract][Full Text] [Related]
3. Impact of COVID-19 on vasooclusive crisis in patients with sickle cell anaemia.
Alkindi S; Elsadek RA; Al-Madhani A; Al-Musalhi M; AlKindi SY; Al-Khadouri G; Al Rawahi B; Al-Ruqeishi S; Al-Yazeedi J; Wali YA; Al Shamakhi S; Al Rawahi M; Pathare AV
Int J Infect Dis; 2021 May; 106():128-133. PubMed ID: 33741487
[TBL] [Abstract][Full Text] [Related]
4. Clinical predictors of poor outcomes in patients with sickle cell disease and COVID-19 infection.
Minniti CP; Zaidi AU; Nouraie M; Manwani D; Crouch GD; Crouch AS; Callaghan MU; Carpenter S; Jacobs C; Han J; Simon J; Glassberg J; Gordeuk VR; Klings ES
Blood Adv; 2021 Jan; 5(1):207-215. PubMed ID: 33570644
[TBL] [Abstract][Full Text] [Related]
5. Association of ABO blood groups with presentation and outcomes of confirmed SARS CoV-2 infection: A prospective study in the largest COVID-19 dedicated hospital in Bangladesh.
Mahmud R; Rassel MA; Monayem FB; Sayeed SKJB; Islam MS; Islam MM; Yusuf MA; Rahman S; Islam KMN; Mahmud I; Hossain MZ; Chowdhury AH; Kabir AKMH; Ahmed KGU; Rahman MM
PLoS One; 2021; 16(4):e0249252. PubMed ID: 33826648
[TBL] [Abstract][Full Text] [Related]
6. Mortality related to sickle cell disease and COVID-19 in Brazil, 2020.
Santo AH
Rev Assoc Med Bras (1992); 2024; 70(4):e20231466. PubMed ID: 38747879
[TBL] [Abstract][Full Text] [Related]
7. A Saudi family with sickle cell disease presented with acute crises and COVID-19 infection.
Al-Hebshi A; Zolaly M; Alshengeti A; Al Qurainees G; Yamani S; Hamdan N; Alwasaidi T
Pediatr Blood Cancer; 2020 Sep; 67(9):e28547. PubMed ID: 32648991
[No Abstract] [Full Text] [Related]
8. The impact of ABO blood groups on clinical outcomes and susceptibility to COVID-19: A retrospective study in an unselected population.
Al-Youha SA; Alduaij W; Al-Serri A; Almazeedi SM; Al-Haddad M; Jamal MH; Shih AW; Al-Sabah SK
Transfusion; 2021 May; 61(5):1631-1641. PubMed ID: 33682150
[TBL] [Abstract][Full Text] [Related]
9. Impact of COVID-19 Infection on 24 Patients with Sickle Cell Disease. One Center Urban Experience, Detroit, MI, USA.
Balanchivadze N; Kudirka AA; Askar S; Almadhoun K; Kuriakose P; Fadel R; Dabak V
Hemoglobin; 2020 Jul; 44(4):284-289. PubMed ID: 32722950
[TBL] [Abstract][Full Text] [Related]
10. COVID-19 Presentation in Patients with Sickle Cell Disease: A Case Series.
Chen-Goodspeed A; Idowu M
Am J Case Rep; 2021 May; 22():e931758. PubMed ID: 33941758
[TBL] [Abstract][Full Text] [Related]
11. Clinical outcomes of COVID-19 in patients with sickle cell disease and sickle cell trait: A critical appraisal of the literature.
Hoogenboom WS; Alamuri TT; McMahon DM; Balanchivadze N; Dabak V; Mitchell WB; Morrone KB; Manwani D; Duong TQ
Blood Rev; 2022 May; 53():100911. PubMed ID: 34838342
[TBL] [Abstract][Full Text] [Related]
12. ABO blood groups and risk of covid-19.
Yalaoui S; Fakhfakh R; Tritar F; Chaouch N; Mestiri T; Besbes M; Hamzaoui A
Tunis Med; 2020 Dec; 98(12):888-891. PubMed ID: 33479990
[TBL] [Abstract][Full Text] [Related]
13. Varying presentations and favourable outcomes of COVID-19 infection in children and young adults with sickle cell disease: an additional case series with comparisons to published cases.
Appiah-Kubi A; Acharya S; Fein Levy C; Vlachos A; Ostovar G; Murphy K; Farrell A; Brower D; Lipton JM; Wolfe L; Aygun B
Br J Haematol; 2020 Aug; 190(4):e221-e224. PubMed ID: 32652551
[No Abstract] [Full Text] [Related]
14. COVID-19 in patients with sickle cell disease: A single center experience from Ohio, United States.
Sahu KK; George L; Jones N; Mangla A
J Med Virol; 2021 May; 93(5):2591-2594. PubMed ID: 33480063
[No Abstract] [Full Text] [Related]
15. Side effects following COVID-19 vaccination in pediatric patients with sickle cell disease.
Belsky JA; Carroll WR; Feliciano A; Jacob SA
Pediatr Blood Cancer; 2023 Mar; 70(3):e30193. PubMed ID: 36583456
[TBL] [Abstract][Full Text] [Related]
16. The association of ABO blood group with the asymptomatic COVID-19 cases in India.
Singh PP; Srivastava AK; Upadhyay SK; Singh A; Upadhyay S; Kumar P; Rai V; Shrivastava P; Chaubey G;
Transfus Apher Sci; 2021 Dec; 60(6):103224. PubMed ID: 34366234
[TBL] [Abstract][Full Text] [Related]
17. Association Between ABO and Rh Blood Groups and SARS-CoV-2 Infection or Severe COVID-19 Illness : A Population-Based Cohort Study.
Ray JG; Schull MJ; Vermeulen MJ; Park AL
Ann Intern Med; 2021 Mar; 174(3):308-315. PubMed ID: 33226859
[TBL] [Abstract][Full Text] [Related]
18. Coronavirus Disease 2019 Infection in Children With Sickle Cell Disease: Case Series From Oman.
Al Sabahi A; Al Maskari N; Al Busaidi I; Albiroty KA; Alkhamisy A; Al Hinai K; Al Hinai M; Al Mashaikhi N; Alkendi J
J Pediatr Hematol Oncol; 2021 Oct; 43(7):e975-e978. PubMed ID: 33512869
[TBL] [Abstract][Full Text] [Related]
19. Questioning the association between ABO type and outcomes in patients with COVID-19.
May JE; McGwin G; Gangaraju R; Paschal R; Weaver K; Lima JLO; Marques MB
Ann Hematol; 2021 Dec; 100(12):3081-3082. PubMed ID: 33205336
[No Abstract] [Full Text] [Related]
20. Incidence of SARS-COV-2 infection in sickle cell patients presenting with a painful crisis: A 12-month prospective cohort study.
Konté K; Nur E; Tang MW; Heijmans J; van Tuijn CFJ; Biemond BJ
Int J Lab Hematol; 2022 Apr; 44(2):e87-e90. PubMed ID: 34651455
[No Abstract] [Full Text] [Related]
[Next] [New Search]
